Lemmer, YolandySemete, BBooysen, LKalombo, LonjiKatata, LJones, ATAlexander, CKhati, MSwai, HSVerschoor, JA2010-12-062010-12-062010-06Lemmer, Y, Semete, B, Booysen, L et al. 2010. Targeted nanodrug delivery systems for the treatment of Tuberculosis. 3rd International CDTM symposium, Cardiff, UK, 26-28 June 2010, pp 1http://hdl.handle.net/10204/45973rd International CDTM symposium, Cardiff, UK, 26-28 June 2010South Africa currently has the highest incidence of TB per 100000 (358 per 100000) people in the world. In 2007 alone 112000 people died of TB in South Africa, of which 94 000 (72%) were co-infected with HIV. Although TB treatments exist, poor patient treatment compliance and drug resistance pose a great challenge to TB treatment programs worldwide. To improve the current inadequate therapeutic management of TB, a polymeric anti-TB nanodrug delivery system for anti-TB drugs was developed that may enable entry, targeting, sustained release over long periods and uptake of the antibiotics in the cells, hence reducing the dose frequency and simultaneously improving patient compliance.enTuberculosisNanodrug delivery systemsTB treatmentsAnti-TB drugsPatient complianceConference PresentationLemmer, Y., Semete, B., Booysen, L., Kalombo, L., Katata, L., Jones, A., ... Verschoor, J. (2010). Targeted nanodrug delivery systems for the treatment of Tuberculosis. http://hdl.handle.net/10204/4597Lemmer, Yolandy, B Semete, L Booysen, Lonji Kalombo, L Katata, AT Jones, C Alexander, M Khati, HS Swai, and JA Verschoor. "Targeted nanodrug delivery systems for the treatment of Tuberculosis." (2010): http://hdl.handle.net/10204/4597Lemmer Y, Semete B, Booysen L, Kalombo L, Katata L, Jones A, et al, Targeted nanodrug delivery systems for the treatment of Tuberculosis; 2010. http://hdl.handle.net/10204/4597 .TY - Conference Presentation AU - Lemmer, Yolandy AU - Semete, B AU - Booysen, L AU - Kalombo, Lonji AU - Katata, L AU - Jones, AT AU - Alexander, C AU - Khati, M AU - Swai, HS AU - Verschoor, JA AB - South Africa currently has the highest incidence of TB per 100000 (358 per 100000) people in the world. In 2007 alone 112000 people died of TB in South Africa, of which 94 000 (72%) were co-infected with HIV. Although TB treatments exist, poor patient treatment compliance and drug resistance pose a great challenge to TB treatment programs worldwide. To improve the current inadequate therapeutic management of TB, a polymeric anti-TB nanodrug delivery system for anti-TB drugs was developed that may enable entry, targeting, sustained release over long periods and uptake of the antibiotics in the cells, hence reducing the dose frequency and simultaneously improving patient compliance. DA - 2010-06 DB - ResearchSpace DP - CSIR KW - Tuberculosis KW - Nanodrug delivery systems KW - TB treatments KW - Anti-TB drugs KW - Patient compliance LK - https://researchspace.csir.co.za PY - 2010 T1 - Targeted nanodrug delivery systems for the treatment of Tuberculosis TI - Targeted nanodrug delivery systems for the treatment of Tuberculosis UR - http://hdl.handle.net/10204/4597 ER -